FindTrial
Sign In

Carbamazepine Treatment for Cocaine Dependence - 5

Carbamazepine Treatment for Cocaine Dependence

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000191
Enrollment
0
Registered
1999-09-21
Start date
1991-01-31
Completion date
1994-02-28
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

Cocaine Dependence, Carbamazepine

Brief summary

The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.

Interventions

DRUGCarbamazepine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
21 Years to 51 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026